This course covers the pharmacy responsibilities for the MISTIE-III trial: a phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage. This training module will provide protocol specific information for the site trial pharmacists and pharmacy staff to manage the study drug inventory, preparation, documentation and other requirements of the protocol. YOU MUST BE LOGGED IN TO VIEW THIS COURSE. REGISTER HERE.

Register to read more ...